Titan Medical Inc
TSX:TMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Titan Medical Inc
Depreciation & Amortization
Titan Medical Inc
Depreciation & Amortization Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Titan Medical Inc
TSX:TMD
|
Depreciation & Amortization
$120k
|
CAGR 3-Years
-34%
|
CAGR 5-Years
64%
|
CAGR 10-Years
-7%
|
|
|
Profound Medical Corp
TSX:PRN
|
Depreciation & Amortization
$560k
|
CAGR 3-Years
-30%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
20%
|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Depreciation & Amortization
CA$261.4k
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
8%
|
|
|
MedMira Inc
XTSX:MIR
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
O
|
Ondine Biomedical Inc
LSE:OBI
|
Depreciation & Amortization
CA$565k
|
CAGR 3-Years
3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Conavi Medical Corp
XTSX:CNVI
|
Depreciation & Amortization
$791k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
27%
|
CAGR 10-Years
39%
|
|
Titan Medical Inc
Glance View
Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). The company is headquartered in Toronto, Ontario and currently employs 49 full-time employees. The company went IPO on 2008-04-28. The firm is developing its Enos system to become the new standard of care in robotic single access surgery, with dual three-dimensional (3D) and two-dimensional (2D) high-definition vision systems, multi-articulating instruments and an ergonomic surgeon workstation. Its multi-articulated instruments bring fluid to position the effectors for grasping, suturing, cutting and coagulation. The Enos surgeon workstation includes a 3D high-definition display to provide a balance of surgical immersion and situational awareness in the operating room.
See Also
What is Titan Medical Inc's Depreciation & Amortization?
Depreciation & Amortization
120k
USD
Based on the financial report for Jun 30, 2024, Titan Medical Inc's Depreciation & Amortization amounts to 120k USD.
What is Titan Medical Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-7%
Over the last year, the Depreciation & Amortization growth was -79%. The average annual Depreciation & Amortization growth rates for Titan Medical Inc have been -34% over the past three years , 64% over the past five years , and -7% over the past ten years .
